Ampicillin Sodium/Probenecid Sodium

氨苄西林钠/丙磺舒钠

Report date: 2023/03/04 19:33:18

Base Information

Drug NameAmpicillin Sodium/Probenecid Sodium
Drug Alias Name氨苄西林丙磺舒胶囊
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsOtorhinolaryngologic DiseasesGastrointestinal DiseasesUrinary Tract Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Ampicillin SodiumProbenecid Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsOtorhinolaryngologic DiseasesGastrointestinal DiseasesUrinary Tract Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A